about
Difference in myocardial flow reserve between patients with dilated cardiomyopathy and those with dilated phase of hypertrophic cardiomyopathy: evaluation by 15O-water PET.Comparison of myocardial blood flow during dobutamine-atropine infusion with that after dipyridamole administration in normal men.Impact of manual and automated interpretation of fused PET/CT data on esophageal target definitions in radiation planning.Dosimetry of patients submitted to cerebral PET/CT for the diagnosis of mild cognitive impairment.Abdominal masses sampled at PET/CT-guided percutaneous biopsy: initial experience with registration of prior PET/CT images.Preclinical acute toxicity, biodistribution, pharmacokinetics, radiation dosimetry and microPET imaging studies of [(18)F]fluorocholine in mice.Use of radiolabeled monoclonal antibody to enhance vaccine-mediated antitumor effects.In Vivo MRI Assessment of Experimental Schistosomiasis.Radiolabeling of avidin with very high specific activity for internal radiation therapy of intraperitoneally disseminated tumors.Ambient radiation levels in positron emission tomography/computed tomography (PET/CT) imaging center.Clinical value of positron emission tomography with FDG for recurrent ovarian cancer.Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core.Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer.Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation.Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer.Optimal scan time for evaluating pancreatic disease with positron emission tomography using F-18-fluorodeoxyglucose.Effect of caffeine intake on myocardial hyperemic flow induced by adenosine triphosphate and dipyridamole.What is the most appropriate scan timing for intraoperative detection of malignancy using 18F-FDG-sensitive gamma probe? Preliminary phantom and preoperative patient study.Quantification of human nicotinic acetylcholine receptors with 123I-5IA SPECT.5-[123I]Iodo-A-85380: assessment of pharmacological safety, radiation dosimetry and SPECT imaging of brain nicotinic receptors in healthy human subjects.18F-FDG and 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy.Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation.Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine- and [(123)I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites.Comparison of myocardial blood flow induced by adenosine triphosphate and dipyridamole in patients with coronary artery disease.Temporal change in human nicotinic acetylcholine receptor after smoking cessation: 5IA SPECT study.Evaluation of the combined effects of target size, respiratory motion and background activity on 3D and 4D PET/CT images.Hepatocyte targeting of 111In-labeled oligo-DNA with avidin or avidin-dendrimer complex.The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level <0.5 ng/mL.18F-FDG-PET-based tumor delineation in cervical cancer: threshold contouring and lesion volumes.Motion artifacts occurring at the lung/diaphragm interface using 4D CT attenuation correction of 4D PET scans.FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival.Phase 2 trial of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced cervical cancer.(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy.FDG-PET/CT tumor segmentation-derived indices of metabolic activity to assess response to neoadjuvant therapy and progression-free survival in esophageal cancer: correlation with histopathology results.Malignant phenotype and two SDHD mutations in a family with paraganglioma syndrome type 1.The effect of nitroglycerin on myocardial blood flow in various segments characterized by rest-redistribution thallium SPECT.FDG-PET of autoimmune-related pancreatitis: preliminary resultsEnhancement of the therapeutic outcome of radio-immunotherapy by combination with whole-body mild hyperthermiaRadioiodine concentration by the thymus in differentiated thyroid carcinoma: report of five casesMetabolic pattern of glomic tumor by F-18 FDG PET/CT
P50
Q31113767-D9853D3A-3E17-42CB-B746-3514ACD83241Q31818239-6105D7C8-72CD-411F-A54C-F7631E36A0DEQ33386589-EBA55778-23AF-453B-87ED-3B0969431DC2Q35124047-11A8E15B-6396-42ED-91F4-D846535EE634Q37767331-244101C3-63F2-4B36-8067-76935585768CQ39503689-A9F924D2-D554-46B0-84A5-AA5A3217AB3FQ40015593-1BF6F553-871E-4FCB-95DE-EB9A0BE7A015Q40265088-391E4482-1202-4160-8005-77E36D4C2944Q40632081-44D38551-288B-4482-9775-367EA54FA3A1Q42073190-30FAF45D-BA3C-483C-89A4-FD649610E3FEQ43617413-BC9EEC62-673B-494F-801F-AA1EA1B86415Q43759382-29D603A1-7F90-47A3-B983-C8CAF3BFB79EQ43890713-73964667-52FC-4A28-9BC5-4166B819EBBAQ43982604-13F18C30-A990-4EEB-A84A-725E15BB78E3Q44503602-E1C19E0D-125C-479A-80F2-90E6F4C42B4FQ44583130-20496A62-45A4-4D59-8FC4-98CB1802419BQ44891181-0371024B-F877-438E-BD32-F0EF42105485Q44935187-2BC2C356-5D1C-4289-B344-61CC0A950C23Q45044260-7046C599-69EA-4852-95A3-30CF34854835Q45053629-0906B817-3AF4-4C5E-AF1D-7ADEBD96D49CQ45245511-4EEB577E-C5F2-41CC-91A7-BA21A889758DQ46842227-7A6B7F9F-D305-4B23-B145-DB9CE728715CQ46844979-EA7A4B35-CFA6-4DE9-9B38-4234A80F00E9Q46917942-B484D12C-FF45-4C66-B956-8D649DE3106DQ46945327-95FE6CAF-CDA5-4529-BD1D-9C370ABB61EDQ47229182-257F26B9-A388-4D67-9BF4-FE42E286D765Q47971983-1EF99E69-021F-443D-A7AC-B173861B2757Q50881880-A6B8211D-B9BB-4D96-94F1-99B0BC19BA10Q51340251-040E6BBC-2370-481F-B81C-882BFC91FAF1Q51496759-FA667FE4-1831-4ACC-926E-2FBA64A75998Q51617036-C5069B80-1C78-4EF4-B03A-F9B8CFF577F1Q53093760-EA652E68-D3A0-40C5-9E28-4B1EBF35DAF6Q53132955-F3B45EAD-00F9-400D-A994-D0CC5A140C90Q53466353-8104E78C-8B20-4444-8153-24EAB7CCDD0BQ53566102-1E6C8AF5-CC6A-4EFE-B605-574F2C14A696Q53653316-F841EC7E-F301-4F88-910D-A5776909A525Q73466888-E8ADDB4F-F10E-4E3C-A28D-986434669684Q74129145-3BF31E9A-7184-4203-84F4-751B4253D0D1Q84958832-8BBEE4B7-59E7-491C-BA67-82DEBB5D09F8Q85047530-9D6ECD64-7771-4DCB-9D4F-B5AC0B93E665
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marcelo Mamede
@ast
Marcelo Mamede
@en
Marcelo Mamede
@es
Marcelo Mamede
@nl
Marcelo Mamede
@sl
type
label
Marcelo Mamede
@ast
Marcelo Mamede
@en
Marcelo Mamede
@es
Marcelo Mamede
@nl
Marcelo Mamede
@sl
altLabel
Mamede M; M Mamede; MH Mamede
@en
prefLabel
Marcelo Mamede
@ast
Marcelo Mamede
@en
Marcelo Mamede
@es
Marcelo Mamede
@nl
Marcelo Mamede
@sl
P1053
A-1751-2014
P106
P21
P31
P3829
P496
0000-0001-5818-0954